Last reviewed · How we verify
Myxedema coma
Approved treatments
- Triostat · Pfizer
Triostat works by mimicking the natural thyroid hormone, l-Triiodothyronine, to stimulate the thyroid hormone receptor alpha. - Triiodothyronine · Northwell Health
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Myxedema coma patent landscape — cliff calendar, originator estates, attackable patents
- Myxedema coma treatment landscape brief
- Myxedema coma treatment updates RSS
Frequently asked questions about Myxedema coma
What drugs treat Myxedema coma?
Tracked treatments include Triostat, Triiodothyronine.
What is the treatment for Myxedema coma?
Standard treatment for Myxedema coma includes Triostat, Triiodothyronine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Myxedema coma patent cliff · Myxedema coma CI report
- Treatment: Triostat · Pfizer
- Treatment: Triiodothyronine · Northwell Health
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing